Literature DB >> 32228278

Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?

Robert W Motl1, Brian M Sandroff1, Ralph Hb Benedict2, Elizabeth A Hubbard3, Lara A Pilutti4, Bradley P Sutton5.   

Abstract

BACKGROUND: There is evidence of cognitive-motor coupling in multiple sclerosis (MS) such that the slowing of cognitive processing speed correlates with the worsening of walking speed and endurance.
OBJECTIVE: The current study first established the presence of cognitive-motor coupling and second examined the possibility that volumes of subcortical gray matter (SGM) structures and aerobic capacity might explain the coupling of cognitive and motor functions in persons with MS.
METHODS: We included data from 62 persons with clinically definite MS who underwent assessments of cognitive processing speed, walking performance, and aerobic capacity, and completed magnetic resonance imaging (MRI) within 7 days of the aforementioned assessments.
RESULTS: The strong correlations between cognitive processing speed and walking performance were attenuated in magnitude and not statistically significant when controlling for aerobic capacity alone and aerobic capacity and SGM volumes together. The associations between cognitive processing speed and walking performance remained statistically significant when controlling for SGM volumes alone.
CONCLUSION: Aerobic capacity may be an important target for neurorehabilitation-based approaches for managing co-occurring cognitive and motor dysfunction in MS.

Entities:  

Keywords:  Cognition; aerobic fitness; magnetic resonance imaging; neurorehabilitation; walking

Mesh:

Year:  2020        PMID: 32228278     DOI: 10.1177/1352458520914822

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  1 in total

1.  Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Cristina A F Román; Glenn R Wylie; John DeLuca; Gary R Cutter; Ralph H B Benedict; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2022-06-19       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.